TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion. December 2, 2005